NL-OMON37787已完成不适用
Impact of airflow limitation in chronic heart failure - ALICE-HF
Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •documented HeartFailure based on left ventricular dysfunction (irrespective of ejection fraction) (following current ESC guidelines)
- •age patients 50 years or older
排除标准
- •Patients for whom spiromerty is contra indicated
- •patients with recent surgery, myocardial infarction or cardiac decompensation, lower respiratory tract infection or stroke
研究者
相似试验
已完成
不适用
Airflow Limitation in Cardiac Diseases in Europe (the ALICE study).COPDIschemic Heart Disease1008220610038716NL-OMON35465GlaxoSmithKline400
已完成
不适用
The impact of continuous positive airway pressure (CPAP) on aortic aneurysms in patients with obstructive sleep apneaobstructive sleep apnea aortic aneurysmJPRN-UMIN000011592Graduate School of Medicine, Kyoto University70
招募中
3 期
Fluid REStriction in Heart failure versus liberal fluid UPtake: the FRESH-UP study10019280Heart failurechronic heart failureNL-OMON52269Radboud Universitair Medisch Centrum506
已完成
不适用
1) Pulmonary function in stable chronic heart failure (CHF). 2) COPD prevalence, underdiagnosis and overdiagnosis in stable CHF patients and its independent predictors. 3) Systemic inflammation in COPD and stable CHF: is there a synergistic effect?1001928010006436systemische inflammatiechronic bronchitis/emphysemaCOPDNL-OMON33134Rijnstate Ziekenhuis369
招募中
不适用
Effects of continuous positive airways pressure (CPAP) therapy on cardiovascular risk factors in type 2 diabetic patients with newly-diagnosed sleep apnoeaACTRN12609000419268School of Medicine and Pharmacology, University of Western Australia100